Fact CheckerSign in

NCT05724433Recruiting

VIrtual Care To Improve Outcomes and RecoverY From Heart Failure Hospitalization

VIrtual Care To Improve Outcomes and RecoverY From Heart Failure Hospitalization (VICTORY-HF) RCT

Source: ClinicalTrials.gov · Last updated 7 Aug 2026

Brief summary (registry, in English)

The clinic visits (intervention) will continue for 90 days, which represents the follow-up period for the primary medication and health status outcomes. The co-primary clinical outcomes will be obtained at 180 days.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
891 (estimated)
First submitted
31 Aug 2019
Start date
23 Jan 2023
Primary completion date
30 Sept 2026
Lead sponsor
Population Health Research Institute
NCT number
NCT05724433

What you commit to

  • Study type: Interventional
  • Planned participants: 891
  • From 23 Jan 2023 to the primary completion date, 30 Sept 2026
  • 9 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Receiving palliative care or expected life expectancy \< 6 months

Other illness

  • Unable to self-assess or communicate symptoms (e.g. clinically evident dementia)
  • Severe valve disease
  • Recipient of or on waiting list for LVAD or cardiac transplant
  • Complex congenital heart disease, hypertrophic obstructive cardiomyopathy, or amyloid cardiomyopathy
  • Severe lung disease with symptoms on minimal exertion, forced expiratory volume during 1 second (FEV1) \< 1 litre, severe pulmonary hypertension with RVSP \> 60 mm Hg, or on home oxygen
  • Active malignancy

Lab values

  • Severe kidney disease (persistent eGFR \< 30 mL/min/1.73m2)

Other

  • Died or left hospital before medically advised hospital discharge
  • Unable to engage with digital health technology or follow up

Who the study is looking for

  • Adult patients ≥ 18 years old who:
  • Are being discharged after hospitalization or urgent visit for HF as
    • a primary diagnosis or
    • significant complication (prolonging length of stay) of another diagnosis OR Have been referred for an initial consult at a cardiology clinic within 1 week of hospitalization or urgent visit for HF as a primary or secondary diagnosis, as described above.
  • Have left ventricular ejection fraction (LVEF) \< 50% within the preceding 3 months.
  • Have NT-proBNP of \> 900 pg/ml during hospital admission or within 7 days after discharge from the ED
  • Have a mailing address for patient or caregiver
  • Provide verbal consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (9)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hamilton General Hospital
Coordinator of this site? Confirm its status
HamiltonCanadaRecruiting
Juravinski Hospital Cancer Centre
Coordinator of this site? Confirm its status
HamiltonCanadaRecruiting
St. Joseph's Healthcare Hamilton
Coordinator of this site? Confirm its status
HamiltonCanadaRecruiting
Thunder Bay Regional Health Sciences Centre
Coordinator of this site? Confirm its status
Thunder BayCanadaNot yet recruiting
Unity Health Toronto
Coordinator of this site? Confirm its status
TorontoCanadaRecruiting
Fattouma Bourguiba Hospital
Coordinator of this site? Confirm its status
MonastirTunisiaRecruiting
Hedi Chaker Hospital
Coordinator of this site? Confirm its status
SfaxTunisiaRecruiting
Sahloul Hospital
Coordinator of this site? Confirm its status
SousseTunisiaRecruiting
Military Hospital
Coordinator of this site? Confirm its status
TunisTunisiaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.